香港脊髓性肌萎缩症患者敦促政府为成人扩展补贴药物选项，包括注射疗法，以提升生活质量。香港神经肌肉疾病协会会长Lui Man-lam周日在记者会上表示，今年初已推出25岁以上患者的口服药补贴，但成人仍缺乏注射疗法的公共资助。
脊髓性肌萎缩症患者表示，一些人因成年后缺乏负担得起的护理而病情恶化。Lui Man-lam在周日记者会上指出，香港政府虽于今年第一季度通过社区关怀基金为25岁以上患者提供口服药补贴，但注射疗法仍未覆盖成人。
“我们主张两种治疗选项享有同等补贴——并非出于偏好，而是因应个体医疗需求，”Lui表示。
脊髓性肌萎缩症是一种遗传性神经肌肉疾病，脊髓和下脑干运动神经元逐步退化，导致肌肉无力，影响运动、吞咽和呼吸。香港于2018年开始补贴18岁以下患者的注射治疗，次年通过社区关怀基金扩展至两种其他疾病类型。口服药物于2021年注册并供应给儿童患者，2025年底开放25岁以上患者注册，今年第一季度起提供补贴。
A Japanese health panel has approved national health insurance coverage for Sumitomo Pharma's Amchepry, an iPS cell-derived treatment for Parkinson’s disease. The move makes it the world's first commercialized medical product from iPS cells.
由 AI 报道
Hong Kong Secretary for Labour and Welfare Chris Sun Yuk-han announced on Friday that authorities will not impose a monthly cap on subsidised trips under the HK$2 transport fare scheme for eligible elderly and people with disabilities. Data showed an average of only about 450 people exceeded 240 trips a month out of 2.7 million beneficiaries.
The Korean government's plan to extend National Health Insurance coverage to hair-loss medication is facing growing criticism from patient groups and medical experts.
由 AI 报道
Actress Valentina Bassi described Javier Milei's government's project to reform the disability law as 'nefarious' and a 'step back 30 years.' She argued that deregulating the unified nomenclature would make access to therapies depend on individuals' finances. Bassi, mother of a teenager with autism, defended the current system that ensures equal opportunities.
The Senate plenum approved a legislative project to bolster care and protection for older adults amid rising indigence and assaults on this demographic. Promoted by Senator Karina Espinosa, the initiative reforms state fund management and toughens penalties for neglect. It aims to optimize resources such as the elderly welfare stamp.